MESOCOSM: A mesocosm database management system for environmental nanosafety.

Database management system Environmental exposure and hazards FAIR data Mesocosm testing Risk assessment

Journal

NanoImpact
ISSN: 2452-0748
Titre abrégé: NanoImpact
Pays: Netherlands
ID NLM: 101676795

Informations de publication

Date de publication:
01 2021
Historique:
received: 23 09 2020
revised: 26 11 2020
accepted: 15 12 2020
entrez: 13 5 2022
pubmed: 1 1 2021
medline: 20 5 2022
Statut: ppublish

Résumé

Engineered nanomaterials (ENMs) are intentionally designed and produced by humans to revolutionize the manufacturing sector, such as electronic goods, paints, tires, clothes, cosmetic products, and biomedicine. With the spread of these ENMs in our daily lives, scientific research have generated a huge amount of data related to their potential impacts on human and environment health. To date, these data are gathered in databases mainly focused on the (eco)toxicity and occupational exposure to ENMs. These databases are therefore not suitable to build well-informed environmental exposure scenarios covering the life cycle of ENMs. In this paper, we report the construction of one of the first centralized mesocosm database management system for environmental nanosafety (called MESOCOSM) containing experimental data collected from mesocosm experiments suited for understanding and quantifying both the environmental hazard and exposure. The database, which is publicly available through https://aliayadi.github.io/MESOCOSM-database/, contains 5200 entities covering tens of unique experiments investigating Ag, CeO

Identifiants

pubmed: 35559777
pii: S2452-0748(20)30082-3
doi: 10.1016/j.impact.2020.100288
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100288

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Ali Ayadi (A)

CEREGE, CNRS, Aix Marseille Univ, IRD, INRAE, Coll France, Aix-en-Provence, France. Electronic address: ayadi@cerege.fr.

Jérôme Rose (J)

CEREGE, CNRS, Aix Marseille Univ, IRD, INRAE, Coll France, Aix-en-Provence, France; Duke university, Civil and Environmental Engineering, Durham, USA.

Camille de Garidel-Thoron (C)

CEREGE, CNRS, Aix Marseille Univ, IRD, INRAE, Coll France, Aix-en-Provence, France.

Christine Hendren (C)

Duke university, Civil and Environmental Engineering, Durham, USA.

Mark R Wiesner (MR)

Duke university, Civil and Environmental Engineering, Durham, USA.

Mélanie Auffan (M)

CEREGE, CNRS, Aix Marseille Univ, IRD, INRAE, Coll France, Aix-en-Provence, France; Duke university, Civil and Environmental Engineering, Durham, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH